The Banner
July 17, 2026
Meredith Cohn
Excerpt:
Over time, the savings to insurance plans and the public should be immense, and access to drugs should expand, said Vincent DeMarco, president of the advocacy group Maryland Health Care for All Coalition.
An analysis commissioned by the group found limits on Ozempic alone could save $165 million when caps are fully implemented.
“We have to deal with the underlying problem,” he said of the huge costs to plans and the public.
“The Prescription Drug Affordability Board took two big steps to make that happen with Jardiance and Ozempic.”
Read the full article at TheBanner.com
Last modified: July 17, 2026
